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INTRODUCTION 
Global technological competition and breakthroughs 
driven by science and engineering had been resulting 
amalgamation of features of nature and science at 
nanoscale. This is bearing foundation of new knowledge, 
innovation, and integration of technology. It stemming in 
production of nanomaterials, the novel materials and 
devices whose properties never envisioned before. 
Nanomaterials are devising with nanotechnology have 
potential in rendering products with novel properties in 
diverse domain 1-4. 
Usefulness of nanotechnology is exploring for producing 
safer and appealing pharmaceuticals, safe and more 
nutritious and appealing foods, and for protecting or 
remediating environment. In remediation of environment 
is through pollution prevention, treatment, and cleanup; 
combating long-term problems at hazardous waste sites; 
and replacing current practices for site remediation 1-4. 
Nanotechnology-based products are marketing as 
electronic items, stain-resistant clothing, self-cleaning 
glass, paints, sports equipment, biotechnology products, 
nanopharmaceuticals, transparent sunscreens, and so on. 
Introduction potentially of nanomaterial bearing products 
is broadening gradually and having expectation for 
enhanced importance in near future 1-4. 
Nanopharmaceuticals are the manufactured 
nanomaterials designed with specific surface properties 
and chemistries for achieving wished novel 
physicochemical properties. These confer potential and 
novel benefits concurrently may peril, as these may act 
differently, comparing natural materials. Possible 
benefits over possible risks of them remain unclear. 
These may have differing biological and chemical 
properties comparing their macro form. Thus may be 
periling so many aspects of human life and environment 
and their consequences on human and environmental 
health became a concerns. Bearing of ecotoxicological 
properties and poorly understood potential risks might 
escort unintended consequences like irreversible damage 
1-5. 
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ABSTRACT 
Usefulness of nanotechnology is exploring for producing safer and appealing pharmaceuticals. Those devising with said 
technology has specific surface chemistries and properties, for achieving wished novel physicochemical properties. These 
being manufactured nanomaterials presented as nanopharmaceuticals bearing dissenting biological and chemical properties 
comparing their macro form. Comparing natural nanomaterials, manufactured nanomaterials may act differently conferring 
potential and novel benefits and concurrently may peril. Their dispersion and shading into environment from the composite 
material may or may not associate with aging and degradation. Major concern bobbing up from their dispersal and shading is 
fate and ecological consequences and pollution of aquatic system. This may be periling diverse aspects of human life and 
environment, and causing ecotoxicological effects periling environment and ecology. Diverse remediation process adopting for 
nullifying ecotoxicological effects of nanomaterials in aquatic system. However, biological systems are receiving attentions for 
remediating it and process is terming ‘bioremediation’. This process be exploiting to adsorb or sequester pollutants and to 
remove them. Bioremediation process is considering as novel, improved and efficient methods for degrading and sequestering 
pollutants of water, seeded nanomaterials. Available literatures are unable to provide insight on nanopharmaceuticals and their 
bioremediation. In this regard, information collected and presented as a handy reference. This insight features on 
bioremediation of nanopharmaceuticals and has applicability in nullifying their ecotoxicological effects. 
Key Words: bioremediation, ecotoxicological, effects, nanomaterials, nanopharmaceuticals, nanotechnology. 
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Questions/concerns on the safety issues of 
nanopharmaceuticals include their fate in human, their 
fate and ecological consequences, and so on. Major 
concern bobbing out is ecological consequences 
followed to their dispersion and shading into 
environment from the composite material may or may 
not associate with aging and degradation. These upon 
dispersion and shading into aquatic system pollute it 1-4. 
Ecotoxicological effects of dispersed and seeded 
nanomaterials from composite nanopharmaceuticals 
periling environment and ecology. Reports on 
ecotoxicological effects are available while concerns 
intensifying possible impact on plants, animals, 
microorganisms, and ecosystems 6-12. 
Nowadays, diverse remediation process adopting for 
nullifying ecotoxicological effects of nanomaterials. 
Amongst them biological systems are receiving 
attentions for remediating aquatic system. Use of 
biological system in remediation process of environment 
is termed as ‘bioremediation’ 13. 
Bioremediation process be exploiting to adsorb or 
sequester pollutants and to remove them from water. It is 
considering as novel, improved and efficient methods of 
water purification be using for degrading organic 
pollutants of water 13. 
Present work is insights bioremediation of 
nanopharmaceuticals. Laid information has applicability 
in complying issues adjoining use of nanotechnology and 
pollution abatement of nanopharmaceuticals. 
NANOPHARMACEUTICALS AND 
NANOTECHNOLOGY  
A material may have diverse optical, electrical, 
magnetic, mechanical and chemical properties at assorted 
size scales. Over past two decades, this desperate 
concept is stemming scientists and engineers in 
mastering the intricacies at nanoscale level. Manipulation 
of structures at the atomic level is developing newer 
technical methods for more precise and controlled 
production of novel materials and devices. These be 
terming as nanomaterials are devising with the 
nanotechnology. ‘Nanotechnology’ is the understanding 
and control of matter at dimensions between 
approximately 1 and 100 nanometres, where unique 
phenomena enable novel applications 1-4. 
Integration of nanotechnology and pharmaceuticals 
synergizes effect of pharmaceutical mothering 
nanopharmaceuticals. The effort is to abreast improving 
performance of medications, cosmetics, delivery 
systems, and diagnostics. Improving performance is 
abreast in increasing efficacy, tolerability, specificity, 
stability, patient compliance, therapeutic index, and so 
on. In addition, is in nullifying toxicities and improving 
marketability 1-4. 
Enormous potential of nanotechnology bobbing up in 
devising nanopharmaceuticals is under extensive study. 
Pharmaceuticals containing nanomaterials presented as 
nanodosage form, nanotherapeutics, and nanodevices. 
These having potential in revolutionising offering of 
device for drug targeting or site-specific controlled 
delivery, and presenting of differential device-activity in 
dissimilar physiological environments, under direction of 
an external operator or physician. In addition, efforts is 
presenting them as disinfectants, cosmetics, and  
biosensor or bio-tracer based diagnostic agent for 
detecting toxins, pathogens, volatile compounds, and 
organic components of body fluids; and for monitoring 
diseases 1-4. 
Semi-biological nanodevices may be offering versatile 
therapeutic services demonstrating unitary biochemical 
activities. Nanodevices amalgamating imaging and 
therapeutic function can provide therapeutic intervention 
concurrent with prognostic information 1-4. 
Nanovesicles may be vesicular systems encapsulates 
drug in a cavity of polymeric membrane. Polymeric 
nanodevices with diverse functionality were being 
designing. Vesicular nanodevices have poor kinetic 
stability comparing nanoparticles 1-4.  
Nanodevice systems are designing with diverse 
functionality. Type of process or technique and materials 
is bearing for wished physicochemical properties and 
wished therapeutic objective. Biodegradable and non-
biodegradable polymers of natural or synthetic origin is 
using for devising them 1-4. 
Adsorbing or grafting of molecules on surface of 
nanodevice modifies its surface property modifying 
interaction with intestinal mucosa. Ligand molecule like 
glycoproteins, antibodies or peptides confers targeting 
while hydrophilic molecules like polyethylene glycol 
improve transcytosis. Adsorbing, grafting, or coating of 
them with mucoadhesives improves gastric retention 
time 3, 4, 14-18. 
BEHAVIOUR OF NANOPHARMACEUTICALS 
Nanopharmaceuticals devised with specific surface 
properties and chemistries that were not likely to be 
observable with natural nanomaterials. Consensus on 
them is the engineered nanomaterials contained in it may 
act differently comparing natural one 1-6. 
Entry of nanopharmaceutical in human body is through 
gastrointestinal (GI) -tract, skin and or lungs. Concern on 
their safety was rising with similar properties as 
comparable with pathogenic particles 12, 19, 20. Evidence 
exhibiting uptake and internalization of them by diverse 
type of mammalian cells, and their ability to cross the 
cell membrane are available 21-23. They were more likely 
to penetrate the skin unpredictably to significant extent 
24. 
Factors playing majorly in bearing of toxicity by 
nanopharmaceuticals are size dependency for their 
uptake, increased concentration and exposure time, and 
large surface area 25-28. In addition, their inhalation at 
elevated concentrations may cause inflammatory 
reactions in lungs and adverse effects in the nervous and 
cardiovascular systems 24. 
Nanomaterials cause oxidative stress in the liver, harm 
the brain associated with higher Blood Brain Barrier 
permeability, and activate blood platelets leading to clot 
formation 24. Ferric oxide nanoparticles upon inhalation 
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may uptake by cells causing oxidative stress response at 
much higher level 29. While it upon internalization by 
cells leading to cell death and may persist in biological 
systems leading to potentially long-term effects. Possible 
long-term effects may due to mutagenic influence on 
organisms through DNA damage, lipid peroxidation, and 
in vivo oxidative protein damage 30, 31. Internalization of 
dispersed C60 fullerenes results morphological changes 
in the vascular endothelial cells while at elevated 
concentrations could induce lethal effects and cytotoxic 
32, 33. 
Fate of nanomaterials in human was chiefly unknown 34. 
Amongst, paracellular or transcellular route, transport for 
particles across the epithelium of GI-tract, transcytosis 
involved in the uptake of them. Transcytosis is 
dependent on physicochemical properties of 
nanomaterials, physiology of the GI-tract, and animal 
model used for study 35. In addition, some aspects of GI 
environment and abrupt change in pH from stomach to 
intestine, disease state of the gut, and presence of other 
macromolecules in food may affect uptake of 
nanomaterials or possible toxicity 24. 
Dispersal and shading potential of nanopharmaceuticals 
depends on its dissolution potential. Said potential is 
influencing by not only properties of dissolution media 
but also quality and quantity, size or surface area, surface 
energy, surface morphology, and aggregation of 
nanopharmaceuticals. The characteristics of exposed 
environment, and the biochemical, physiological, and 
behavioural traits of the exposed organism and adsorbing 
species determines their biological and ecological fate 
and effects 36-38. 
Environmental fate of seeded nanomaterials depends on 
their potentiality for aggregation-segregation and 
adsorption-desorption occurring during interaction 
among themselves and or with natural nanomaterials or 
macromaterials 39-41. Their aggregation potential in 
natural systems depends upon their particle size and 
physical processes like Brownian diffusion, fluid motion, 
and gravity. This potential also determines efficiency of 
their removal from environment 42. 
The surface charge of nanomaterials plays dominantly in 
their adsorption processes that consequently modifies 
their nature 
43-45
. Their mobility can be modifying with 
coating and environmental conditions. Environmental 
conditions like composition of groundwater and 
hydrologic conditions responsible for facilitation or 
inhibition of contaminant transport bears for 
increasing/decreasing toxicity of transported 
contaminants 14-18, 46-50. 
Proponents of nanotechnology and nanopharmaceuticals 
were reviewing concerns along with difficulties referring 
reliability on assessing potential utility and safety prior 
to their continuances. However, proponents on promising 
beneficial properties could hostile governments, damage 
ecology and environment leading to wreak havoc, and 
are becoming a hot topic 12, 51-53. 
ECOTOXICOLOGY OF ENGINEERED 
NANOMATERIALS   
Nanomaterials seeded from nanopharmaceuticals may 
accumulate in the environment can scupper negatively 
affecting stability of many aquatic ecosystems. In 
addition, can be peril human health and the environment. 
Human activities, use, industrial discharges, domestic 
effluents, and improper waste disposal practices are 
seeding nanomaterials from composite 
nanopharmaceuticals 1-4. 
Seeded nanomaterials pollute the aquatic ecosystems and 
may be persistent. Persistency processes involves 
processes of their adsorption, desorption, immobilization 
and accumulation, and transformation and activation. 
Persistency can made them available to benthic 
organisms as well as organisms in the water column 54. 
Their persistence can scupper health and safety of human 
and wildlife 55-57. 
Reports on ecotoxicological effects of manufactured 
nanomaterials were available 7. In addition, lab-scale 
report on uptake of some manufactured materials by fish, 
Daphnia magna, copepods, and other organisms were 
available. Raising peril being on reactivity of 
nanomaterials might affecting plants, animals, 
microorganisms, and ecosystems making up the basis of 
food chains 8-12. Some nanomaterial scupper humans and 
or environment may have damaging potentiality. 
Knowledge on impact of nanomaterials in the 
environment and on human health was still scarce 7, 56-58.  
Nanopharmaceuticals high in lipids serve as the base of 
both pelagic and benthic food chains are categorised as 
persistent organic pollutants (POPs). POPs peril if 
persistent and enter the food chain may be carcinogenic. 
These pollutants may be classing as polycyclic aromatic 
hydrocarbons (PAHs), short and long chain alkanes, and 
Polychlorinated biphenyls (PCBs) 56-59. 
Shorter and longer chain alkanes (< C10 and C20–C40 
respectively) and PAHs are difficult to degrade 60. 
Phenanthrene (PHE) and fluoranthene (FLA) highly 
toxic pollutant belongs to PAHs 61. Nonchlorinated 
aliphatic and aromatic hydrocarbons are hydrophobic 
and pass very slowly to the aqueous phase liquid where 
microorganisms are active and use them as carbon source 
62. The asphaltenes most complex hydrocarbons contain 
nitrogen, sulphur and oxygen, are very resistant to 
microbial degradation 
63, 64
.  
PCBs a worst pollutant is toxic and carcinogenic, widely 
distributed and slowly biodegraded in the environment. 
Their degradation is complex as many are of different 
forms. Some of monohydroxylated PCBs are potent 
endocrine disrupters. Whilst some metabolites of PCBs 
having a hydroxy group at meta or para position reported 
to be involved in developmental neurotoxicity 54, 65, 66. 
Studies emphasizing peril of nanomaterials on health and 
environment, and assessing their life cycle were very 
infancy. Lack of data on said issue is detracting 
consensus. Their damaging potentiality may inaccessible 
due to lack of knowledge on dosage and follow-up of 
traditional risk analysis models. However, their unique 
physicochemical property complicates environmental 
risk assessment 67, 68. 
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Size-dependent adsorption reactivity of crystalline iron-
oxide nanomaterials is responsible for conveying 
adsorbed pollutants like copper, mercury, and silver. 
Consequently is eliciting toxicity on algae, fungi, 
flowering plants, and phytoplankton 69. 
BIOREMEDIATION 
Bioremediation is a waste management technique 
involving use of organisms in removal or neutralization 
of pollutants from a contaminated site. Alternately is a 
‘treatment that uses naturally occurring organisms to 
break down hazardous substances into less toxic or non 
toxic substances’70, 71. 
The technologies of bioremediation can generally be 
classifying as in-situ or ex-situ. In-situ technology 
involves on-site treatment of pollutants, while ex-situ 
involves their removal from the site followed by off-site 
treatment 70, 71. 
Process of bioremediation may occur on its own calling 
natural attenuation or intrinsic bioremediation. 
Alternately may only effectively is occurring through 
addition of fertilizers, oxygen, etc. Added materials 
encourage growth of the pollution-eating microbes 
within the medium terming as biostimulation 70, 72. 
Worldwide the trees, grasses, herbs, and associated fungi 
and microorganisms have being using increasingly for 
remediating polluted sites. Phytoplankton critically 
controls the fate of POPs in the water column as are high 
in lipids and serve as the base of both the pelagic and 
benthic food chains 59, 73. In some cases these uses to 
detoxify organic compounds 71.  
Bioremediation using plants is ‘Phytoremediation’ and 
that using fungi is ‘Mycoremediation’. Phytoremediation 
‘on the brink of commercialization’ is proposing often 
for bioaccumulation of metals. In Europe its market 
potential is still emerging and increasing rapidly while in 
United States the revenues progressing 74-80. 
Mycoremediation follows decomposition of pollutant is 
performing by the mycelium of fungi. Mycelium reduces 
toxins in-situ by stimulating microbial and enzyme 
activity. Some fungi are hyperaccumulators, capable of 
absorbing and concentrating heavy metals in their fruit 
bodies. Microbial consortium exploited for degrading 
PAHs 
71, 81
. 
Oyster mushrooms reduce PAHs to non-toxic 
components in the mycelial-inoculated plots. Wood-
decay fungi are more effective in degrading aromatic 
pollutants, as well as chlorinated compounds, 
components of certain persistent pesticides. 
The algae is exploring in controlling and biomonitoring 
of organic pollutants in aquatic ecosystems. Green algae 
are investigating for bioaccumulation/biodegradation of 
organic xenobiotics 72, 82. The algae are effective in 
hyperaccumulation of heavy metals as well as 
degradation of xenobiotics 83. Application of benthic 
microalgae in restoration of organic-polluted aquatic 
environment (sediments) is in primary stage 84.  
Higher plants and bacteria are exploiting for 
bioextraction and bioremediation of heavy metals and 
organic pollutants 76-79, 85, 86. Bacteria, fungi, algae 
producing enzymes are capable of degrading harmful 
organic compounds by attacking and utilising them. 
They are effective in remediating pollutants of 
hydrocarbon unless polluted medium contains limiting 
nutrients like nitrate, phosphate, and microelements 73, 87.  
Some microorganisms can be degrading PCBs 
aerobically or anaerobically under diverse conditions 88-
91. Dioxygenases aerobically degrade lower chlorinated 
PCBs via co-metabolism resulting complete mineraliza-
tion through ring cleavage 92. However, orthochlorinated 
PCBs inhibit and inactivate dehydroxybiphenyl 
oxygenase, a key enzyme in the degradation pathway 93.  
Brown algae Caepidium antarcticum and Desmarestia 
sp. having ability to associate their exudates with PCBs 
94. Uptake of PCBs congener 2,2',6,6'-
tetrachlorobiphenyl, lipid assimilation, by 
Stephanodiscus minutulus (a phytoplankton) 
significantly altered by nutrient availability which 
subsequently affects transfer to Daphnia pulicaria (a 
zooplankton) 59. Exudates from brown algae 
Ascophyllum nodosum and Fucus sp. are able in 
incorporating organic compounds like amino acids, 
sugars and fatty acids in their lipid stores 95.  
Some microalgae producing enzymes are capable of 
degrading harmful organic compounds transforming 
them into low toxic one 87. Benthic microalgae can 
remediate organically enriched sediments 84. 
Scenedesmus obliquus GH2 (a microalgae) is used to 
construct an artificial microalgal-bacterial consortium 96. 
This isolated microbial consortium upon mixing with 
asphaltenes fastens and improve oxygen consumption 
degrading crude oil and asphaltenes 97. In addition, this 
in different amendments enhances significantly 
degradation efficiency of both aliphatic and aromatic 
hydrocarbons of crude oil. Another consortium of pre-
isolated oil-degrading bacteria in association with three 
species of plants effectively remediates hydrocarbon 98.  
Several microorganisms can metabolise the 
nonchlorinated aliphatic and aromatic hydrocarbons as 
sources of carbon, but due to their hydrophobicity they 
pass very slowly to the aqueous phase liquid where 
microorganisms are active 62. Marine organisms 
including phytoplankton can uptake and accumulate 
several chlorinated hydrocarbons 99. Consensus is that in 
bioremediation of organic contaminants such as PAHs 
oxygen plays key role and can proceed under aerobic and 
anaerobic conditions 100, 101.  
Two algal species, Nitzschia sp. and Skeletonema 
costatum, accumulates and biodegrades two typical 
PAHs, PHE and FLA 102. Accumulation and degradation 
abilities of Nitzschia sp. is more to S. costatum. 
Degradation of FLA by these species was slower making 
it more recalcitrant PAH compound. Removal efficiency 
of PHE-FLA mixture by these species is comparable or 
more comparing that of PHE or FLA alone 101-103.  
An algal-bacterial consortium, Chlorella sorokiniana and 
Pseudomonas migulae (a PHE-degrading strain), 
degrades PHE under photosynthetic conditions without 
needing external supply of oxygen 103. This suggests 
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microalgae releases biosurfactants that could further 
enhance degradation of PHE. Burkholderia cocovenenas 
can degrade PHE liquid culture at pH values ranging 
between 5.5 and 7.5 102, 104. 
During biodegradation of PAHs, phenolics, and organic 
solvents by acclimatized bacteria requires O2 could 
supplied by microalgae 
105
. The bacteria after up taking 
PAHs gets activated in aerobic metabolism by insertion 
of two oxygen atoms supplied by green algae to produce 
either cis-dihydrodiols or phenols 106.  
Nine cyanobacteria, five green algae, two diatoms, and 
one each of red alga and brown alga could oxidize 
naphthalene under photoautotrophic conditions. An algae 
Agmenellum quudruplicatum, strain PR-6 oxidises 
naphthalene to l-naphthol 107. This suggests ability to 
oxidize naphthalene is widely distributed amongst the 
algae 107, 108.  
Once in the aquatic environment, antimicrobials have 
potential inducing adverse effects on ecosystem health 
109. Organochlorine pesticides are lipophilic and 
persistent is accumulating along the food chain. These 
are ubiquitous environmental pollutants in the global 
ecosystem 110, 111. In developing countries, pesticides 
causes up to one million intoxication cases and up to 
20.000 deaths per year 102. 
Phytoremediation of pesticides using transgenic plants is 
emergent nowadays 113. Aquatic plants, Leman minor, 
Elodea canadensis and Cabomba aquatic can remove 
and assimilate three pesticides copper sulphate, 
flazasulfuron and dimethomorph. Their uptake capacity 
is of follow order Lemna minor > Elodea Canadensis > 
Cabomba aquatic 114. Scenedesmus quadricauda is more 
effective in the removal of dimethomorph and 
pyrimethanil and isoproturon 115.  
The green alga Chlamydomonas reinhardtii have great 
ability to accumulate and degrade fluroxypyr 116. and 
prometryne 82. Another green algae Monoraphidium 
braunii is considering as promising species for 
bioremediating aquatic bisphenol 117. In addition, 
freshwater microalgae convert bisphenol A into its 
mono-glucoside 118.  
The marine diatom Amphora coffeaeformis consumes 
mesotrione resulting increase in its cellular density 
119
. 
Algae of Chlorococcum sp. and Scenedesmus sp. degrade 
α-endosulfan to endosulfan sulfate and endosulfan ether. 
The first is major metabolite and latter a minor 
metabolite 120.  
Freshwater systems located in urban or agricultural areas 
exposes microalgae to a multitude of toxicologically 
different pesticides 121. This could hypothesize in the 
appearance of resistant mutants. Thus will 
simultaneously determine arose of new morphological 
populations driven by algaecide-resistant clones 122.  
BIOREMEDIATION BY GENETIC 
ENGINEERING  
Nowadays genetic engineering had been using for 
improving bioremediation of heavy metals and organic 
pollutants. Expression of metal-binding proteins or 
peptides in plants and microorganisms enhances heavy 
metal accumulation and/or tolerance. Said ability of 
expression has great potential in removing heavy metals 
from contaminated aquatic ecosystems 123-126. In this 
regard, the plants either with bacterial or animal 
xenobiotic degrading genes has been successfully tried a 
transgenic approach of engineering 83. Genetic 
engineering can be creating genetically modified 
organism, potentially degrading diverse POPs and 
removing diverse toxic compounds 125-127.  
Transgenic plants and associated bacteria constitute a 
new generation of genetically modified organisms for 
bioremediation. These transgenic organisms are 
developing to degrade or modify POPs 125-132. Transgenic 
algae and microorganisms mutated with bioluminescence 
genes could be using in biomonitoring of organic and 
inorganic pollution 133, 134. Expression of the catabolic 
genes of PCB-degrading microorganisms is a key factor 
for biodegradation of PCBs 135. Transgenic plants 
expressing the bacterial xenobiotic degradation genes 
combine the advantages of both the systems. Firstly, 
more ability of biodegradation by bacteria secondly is 
high biomass and stability of plants for having an ideal 
system for in situ bioremediation of contaminants 86, 136. 
Transgenic Chlamydomonas cells express 
metallothionin, a metal binding protein. These cells grow 
at normal rates in the presence of lethal concentrations of 
cadmium accumulating five-fold more cadmium 
comparing wild type cells 137. Mixotrophy in 
cyanobacteria and microalgae can provide many 
competitive advantages over bacteria and fungi in 
degrading POPs. 
Bioremediation of pharmaceuticals, pesticides, and 
petrochemicals also done with gomeya/cow dung 138. 
Bioremediation of industrial pharmaceutical drugs had 
also been devised 139.  
DEALING WITH THE UNCERTAINTY AND 
PERIL OF NANOTECHNOLOOGY 
Introduction and continuances of nanopahrmaceuticals 
requires reviewing of its proponents. Their potential risks 
understood poorly. Underestimations of this might escort 
to unintended consequences like irreversible damage 5, 12, 
51-53.  
However, advocated promising beneficial effect of 
nanopahrmaceuticals could hostile governments or angry 
individual and damage humans and environment leading 
to wreak havoc and become a hot topic presently. 
Unavailability of data relating toxicity, exposure, and life 
cycle of their applications regulatory decisions were in a 
state of ambiguity. This level of uncertainty may be 
resulting in either forgoing benefits of 
nanopharmaceuticals bearing from too much regulation 
or scupper damages bearing from relaxed regulation 1, 12, 
51-53. 
Contradictory reports highlighting toxicology, gaps in 
research, and possible testing strategies for nanomaterials 
were publishing. Contradicting opinions bearing with 
scarce scientific evidence based harmful/hazardous 
effects is the elimination for need to regulate these by 
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regulatory bodies and industry, and adoption of more 
proactive risk management strategies advocating by non-
government organizations 1, 58. 
Several government and non-government organizations 
had identified health risks and potential environmental 
consequences, and the importance for assessing it. 
Environmental consequences determine hazardous 
effects, fate and transport, and bioaccumulation of 
released/dispersed nanomaterials 1, 20. 
Comparing other pharmaceuticals, nanopharmaceuticals 
have differing material, size, surface, and shape. 
Therefore, general claims cannot be making on 
associated health and other risks. Consequently, 
suggestions had been making to assess their risk and 
toxicity on case-by-case basis 1-4.  
Many factors can be influencing the bioremediation of 
PAHs includes temperature, oxygene, pH, seeding 
potential and ecotoxicity. Temperature considerably 
affects ability of the in situ microorganisms to degrade 
them. In most situations, contaminated sites will not be at 
the optimum temperature for bioremediation throughout 
the seasons of year 100. The solubility of PAHs increases 
with an increase in temperature. Their degradation 
potentiality is dependent on availability of optimum pH 
of contaminated sites 140. 
Combination of microbiological and ecological 
knowledge, and biochemical mechanisms are the 
essential elements for successful in situ and ex situ 
bioremediation using transgenic bacteria and microalgae 
141, 142. Molecular methods and metabolic and genomic 
information will help in identification and selection of 
mixotrophic species of cyanobacteria and microalgae 
with capabilities to degrade organic pollutants. In 
addition, also this will help in monitoring efficiency of 
bioremediation 142. 
CONCLUSION  
Scientists working in the field of nanopharmaceuticals 
were more optimistic with their potential benefits while 
least concerned about risks periling to environment and 
public. Group of experts expecting these will be 
providing novelty in the treatment of human diseases 
whilst others were more concerned for environmental 
contamination and new health problems. Their 
application bears a high level of terror and suspect, was 
likely to turn into controversial topic. None redressing 
the issues with respect to public expectation may lead to 
a social amplification process. 
Application of bioremediation in biomoniroring and 
restoration of aquatic systems favour the phytoextraction 
and biodegradation of many nanopharmaceuticals 
(pollutants). However, there still some persistent 
pollutants, from nanopharmaceuticals, difficult to 
remediate. The genetic engineering can solve this 
problem.  
Transgenic bioremediation process may offering a 
promising tool to improve the absorption and 
bioremediation of many of said pollutants will increase 
phytoplankton tolerance to these pollutants. In addition, 
it is necessary to study and control temperature, pH, 
nutrient availability of aquatic ecosystems and other 
environmental parameters for increasing absorption, 
accumulation and biodegradation of diverse category of 
said pollutants. In fact, these parameters accelerate 
bioremediation process and reduce the time of 
decontamination of an aquatic ecosystem. 
Discussed field will provide opportunities for integrating 
science and technology with social science and 
humanities. Whilst professionals may be updating on 
pros and cons by a well-developed educational 
mechanisms is through intelligent database. 
Governmental and non-governmental system must 
carefully redress health and the environmental 
consequences, necessary for delivering wished benefit 
combating hostilely attitude of public. 
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